Table 3.

SRP-site clinical parameters in response to SRP.

	Before treatment		Re-evaluation		ΔChange
	CAL	PD	CAL	PD	CAL	PD
CA	4.66 ± 1.28	5.00 ± 0.57	3.84 ± 0.92	3.81 ± 0.66	0.77 ± 1.33	1.19 ± 0.64
AA	4.22 ± 0.92	4.87 ± 0.32	4.46 ± 0.89	3.86 ± 0.51	−0.25 ± 1.35	1.01 ± 0.59
HA	4.39 ± 1.30	4.91 ± 0.49	4.12 ± 0.88	3.75 ± 0.59	0.28 ± 1.33	1.16 ± 0.68
ALL	4.43 ± 1.21	4.93 ± 0.48	4.11 ± 0.91	3.79 ± 0.59	0.30 ± 1.36	1.13 ± 0.64
p-Value	0.523	0.666	0.123	0.804	0.077	0.657

CAL and PD at the SRP sites are presented as Mean ± SD in mm. CA, Caucasian Americans; AA, African Americans; HA, Hispanic Americans; ALL, all subject enrolled.